Fagron Resultados de beneficios anteriores
Pasado controles de criterios 4/6
Fagron ha aumentado sus beneficios a una tasa media anual de 7%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 10.1% anual. Los ingresos han ido creciendo a una tasa media de 9.9% al año. La rentabilidad financiera de Fagron es de 16.4%, y sus márgenes netos son de 9.5%.
Información clave
7.0%
Tasa de crecimiento de los beneficios
6.6%
Tasa de crecimiento del BPA
Crecimiento de la industria Healthcare | 13.4% |
Tasa de crecimiento de los ingresos | 9.9% |
Rentabilidad financiera | 16.4% |
Margen neto | 9.5% |
Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Fagron NV (EBR:FAGR)
Oct 07Fagron NV's (EBR:FAGR) CEO Will Probably Find It Hard To See A Huge Raise This Year
May 07The Returns At Fagron (EBR:FAGR) Aren't Growing
Apr 17Is Fagron (EBR:FAGR) A Risky Investment?
Mar 15Earnings Tell The Story For Fagron NV (EBR:FAGR)
Feb 18Fagron (EBR:FAGR) Seems To Use Debt Quite Sensibly
Aug 11Be Wary Of Fagron (EBR:FAGR) And Its Returns On Capital
Jun 10Fagron (EBR:FAGR) Has Announced That It Will Be Increasing Its Dividend To €0.175
May 12An Intrinsic Calculation For Fagron NV (EBR:FAGR) Suggests It's 30% Undervalued
Apr 20Is Fagron (EBR:FAGR) A Risky Investment?
Apr 02Here's Why Fagron (EBR:FAGR) Can Manage Its Debt Responsibly
Oct 14Return Trends At Fagron (EBR:FAGR) Aren't Appealing
Jun 04Fagron (EBR:FAGR) Is Paying Out A Larger Dividend Than Last Year
May 13Is Fagron (EBR:FAGR) Using Too Much Debt?
Apr 13Slowing Rates Of Return At Fagron (EBR:FAGR) Leave Little Room For Excitement
Feb 16Fagron (EBR:FAGR) Has A Pretty Healthy Balance Sheet
Nov 18Fagron (EBR:FAGR) Is Experiencing Growth In Returns On Capital
Sep 25Are Investors Undervaluing Fagron NV (EBR:FAGR) By 45%?
Aug 30Fagron NV (EBR:FAGR) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Aug 08Is Fagron (EBR:FAGR) A Risky Investment?
Jun 15Fagron NV (EBR:FAGR) Shares Could Be 49% Below Their Intrinsic Value Estimate
May 29The Returns At Fagron (EBR:FAGR) Aren't Growing
May 03Here's Why Fagron (EBR:FAGR) Can Manage Its Debt Responsibly
Mar 08Is Fagron NV (EBR:FAGR) A Smart Choice For Dividend Investors?
Feb 22The Returns At Fagron (EBR:FAGR) Provide Us With Signs Of What's To Come
Jan 31Is Fagron NV (EBR:FAGR) Popular Amongst Institutions?
Jan 14How Much Does Fagron's (EBR:FAGR) CEO Make?
Dec 27Are Investors Undervaluing Fagron NV (EBR:FAGR) By 25%?
Dec 14Fagron (EBR:FAGR) Seems To Use Debt Quite Sensibly
Nov 30Should You Be Excited About Fagron NV's (EBR:FAGR) 26% Return On Equity?
Nov 17Is Fagron (EBR:FAGR) Using Too Much Debt?
Aug 23Why Fagron NV (EBR:FAGR) Looks Like A Quality Company
Aug 10Should Fagron (EBR:FAGR) Be Disappointed With Their 64% Profit?
Jul 28Will Fagron (EBR:FAGR) Multiply In Value Going Forward?
Jul 14What Kind Of Shareholder Owns Most Fagron NV (EBR:FAGR) Stock?
Jun 30Desglose de ingresos y gastos
Cómo gana y gasta dinero Fagron. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
30 Jun 24 | 821 | 78 | 205 | 0 |
31 Mar 24 | 792 | 74 | 196 | 0 |
31 Dec 23 | 763 | 71 | 187 | 0 |
30 Sep 23 | 745 | 69 | 181 | 0 |
30 Jun 23 | 727 | 67 | 175 | 0 |
31 Mar 23 | 705 | 69 | 166 | 0 |
31 Dec 22 | 684 | 70 | 158 | 0 |
30 Sep 22 | 655 | 70 | 149 | 0 |
30 Jun 22 | 626 | 69 | 140 | 0 |
31 Mar 22 | 600 | 65 | 136 | 0 |
31 Dec 21 | 574 | 61 | 133 | 0 |
30 Sep 21 | 564 | 58 | 131 | 0 |
30 Jun 21 | 554 | 55 | 129 | 0 |
31 Mar 21 | 555 | 57 | 127 | 0 |
31 Dec 20 | 556 | 60 | 125 | 0 |
30 Sep 20 | 557 | 60 | 125 | 0 |
30 Jun 20 | 558 | 60 | 126 | 0 |
31 Mar 20 | 546 | 58 | 125 | 0 |
31 Dec 19 | 535 | 55 | 125 | 0 |
30 Jun 19 | 496 | 51 | 120 | 0 |
31 Mar 19 | 484 | 47 | 116 | 0 |
31 Dec 18 | 472 | 43 | 113 | 0 |
30 Jun 18 | 444 | 45 | 103 | 0 |
31 Mar 18 | 439 | 46 | 102 | 0 |
31 Dec 17 | 434 | 47 | 101 | 0 |
30 Sep 17 | 433 | 16 | 101 | 0 |
30 Jun 17 | 432 | -14 | 101 | 0 |
31 Mar 17 | 428 | -15 | 100 | 0 |
31 Dec 16 | 422 | -19 | 97 | 0 |
30 Sep 16 | 421 | -25 | 99 | 0 |
30 Jun 16 | 421 | -31 | 101 | 0 |
31 Mar 16 | 474 | -203 | 124 | 0 |
31 Dec 15 | 428 | -25 | 104 | 0 |
30 Sep 15 | 441 | 8 | 105 | 0 |
30 Jun 15 | 455 | 41 | 106 | 0 |
31 Mar 15 | 445 | 38 | 103 | 0 |
31 Dec 14 | 447 | 43 | 102 | 0 |
30 Sep 14 | 418 | 46 | 93 | 0 |
30 Jun 14 | 389 | 49 | 84 | 0 |
31 Mar 14 | 366 | 46 | 77 | 0 |
31 Dec 13 | 343 | 42 | 71 | 0 |
Ingresos de calidad: FAGR tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (9.5%) de FAGR son superiores a los del año pasado (9.3%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de FAGR han crecido un 7% al año en los últimos 5 años.
Acelerando crecimiento: El crecimiento de los beneficios de FAGR en el último año (15.5%) supera su media de 5 años (7% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de FAGR en el último año (15.5%) no superó al de la industria Healthcare 15.2%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de FAGR (16.4%) se considera baja.